Purdue Pharma is expected to forfeit $225 million in its criminal opioid case sentencing
The move clears a key legal hurdle in the company's broader settlement over its role in the opioid crisis
At a glance
What matters most
- Purdue Pharma is expected to forfeit $225 million in a criminal case tied to its marketing of OxyContin.
- The sentencing clears a legal path for the company's broader settlement to take effect.
- Money from the Sackler family and Purdue will go to state and local governments, tribal nations, and individual victims.
- Some families affected by opioid deaths still want criminal charges against the Sackler family.
Across the spectrum
What people are saying
A quick look at how the same story is being framed from different angles.
On the Left
This settlement delivers much-needed funding to communities ravaged by the opioid crisis, but it falls short of holding the Sackler family fully accountable. Immunity for wealthy individuals who profited from addiction underscores deeper flaws in how the legal system treats corporate wrongdoing. True justice would include criminal charges and steeper penalties.
In the Center
The sentencing and settlement represent a pragmatic resolution to a complex legal and public health crisis. While criminal charges against the Sacklers might bring symbolic satisfaction, the priority now is getting resources to affected communities quickly and efficiently-something this agreement is designed to do.
On the Right
Purdue Pharma's punishment reflects the consequences of corporate misconduct, but the focus should remain on personal responsibility and local solutions. The settlement avoids further draining the economy with endless litigation, allowing funds to flow to recovery efforts without setting a dangerous precedent of collective blame.
Full coverage
What you should know
A federal judge is expected to formally sentence Purdue Pharma this week, requiring the company to forfeit $225 million in a criminal case over its role in fueling the opioid epidemic. The penalty stems from the company's misleading marketing of OxyContin, which helped drive widespread addiction and overdose deaths across the U.S. over the past two decades.
The criminal forfeiture is a key step in finalizing a broader settlement that would release the Sackler family, Purdue's former owners, from future civil liability in exchange for contributing up to $6 billion over time. Those funds are meant to support addiction treatment, prevention programs, and community recovery efforts in states, cities, and Native American tribal governments.
While the company pleaded guilty to criminal charges years ago, this sentencing had been delayed due to legal disputes over whether the Sacklers could receive immunity without facing their own criminal charges. That immunity remains controversial. Some families who lost loved ones to opioid overdoses argue it lets the Sacklers avoid real accountability.
"This settlement brings resources to communities that have been devastated for years," said one state attorney general involved in the negotiations. "But for many, justice still feels incomplete without personal consequences for the people who made the decisions at the top."
The U.S. Department of Justice has maintained that the agreement strikes a balance between securing funds for recovery and working within the limits of what's legally enforceable. With the criminal sentence now imminent, the final approval of the bankruptcy settlement is expected to follow in the coming weeks.
Purdue Pharma no longer operates under its original structure. It was dissolved and reorganized under new ownership as part of its bankruptcy process, with the goal of focusing on remediation and public health rather than profit.
The case is one of the most closely watched outcomes of the nationwide legal response to the opioid crisis. While billions have been paid out by drugmakers, distributors, and pharmacies, many advocates say the human toll still outpaces the restitution.
About this author
Zwely News Staff compiles multi-source reporting into concise, viewpoint-aware coverage for readers who want context without noise.
Source Notes
Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case
Under settlement, Sackler family will pay state, local and Native American tribal governments, individual victims and othersSign up for the Breaking News US email to get newsletter alerts in your inboxA judge is expected to sentence the Oxy...
A criminal sentence for OxyContin maker Purdue Pharma clears the way for finalizing its settlement
Some people who lost loved ones to overdose are still pushing for criminal charges against the company's owners.
Previous story
Trump talks up military pressure on Iran while reminiscing about Cook's 'kiss my ass' call
Next story
